Qu Biologics Begins Phase 2 Clinical Trial in Ulcerative Colitis
July 28, 2015 19:33 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 28, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Begins Research Collaboration with Dr. Bruce Vallance at the University of British Columbia to Study SSI Treatment for Inflammatory Bowel Disease
July 14, 2015 09:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 14, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Appoints Jim Pankovich as Vice President, Clinical Operations and Drug Development
June 10, 2015 09:40 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 10, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Granted European Patent for Use of Bacterial Compositions for the Treatment of Cancer
May 11, 2015 10:05 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 11, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics to Present at Bloom Burton Healthcare Investor Conference
April 30, 2015 15:31 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 30, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Opens Clinical Trial Sites in Edmonton and Toronto for Crohn's Disease Clinical Trial
April 24, 2015 15:05 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 24, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Crohn's Disease
March 31, 2015 09:40 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 31, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Begins Research Collaboration with the University of Rochester, New York
March 24, 2015 10:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Named Life Sciences BC Growth Stage Company of the Year
March 04, 2015 10:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 4, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Enrolls First Two Participants in Phase 2a Clinical Trial for Lung Cancer
February 04, 2015 10:05 ET
|
Qu Biologics;BC Cancer Agency
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 4, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...